1. "GSK Faculty"
Formats
  1. Journal Article (13834)
  2. Meeting Abstract (7076)
  3. Review (514)
  4. Book Section (342)
  5. Editorial (307)
  6. Conference Paper (162)
  7. Research Letter (96)
  8. Miscellaneous (45)
  9. Correspondence (38)
  10. Guidelines (32)
  11. Book Whole (22)
Groups
  1. GSK Faculty (22468)
  2. Sloan Kettering Institute Faculty (11482)
  3. Department of Medicine (10529)
  4. Tow Center for Developmental Oncology (TCDO) (6948)
  5. Sloan Kettering Institute Postdocs (6210)
  6. Solid Tumor Oncology Division (5880)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Steven Larson (957)
  3. Jedd Wolchok (905)
  4. Cristina Antonescu (895)
  5. Kenneth Offit (788)
  6. David Solit (779)

More People

Years
  1. 2025 (296)
  2. 2024 (868)
  3. 2023 (1016)
  4. 2022 (1152)
  5. 2021 (1088)
  6. 2020 (1257)

More Years

Publications
  1. Blood (1470)
  2. Journal of Clinical Oncology (1279)
  3. Cancer Research (1104)
  4. Clinical Cancer Research (527)
  5. Modern Pathology (494)
  6. Journal of Nuclear Medicine (474)

More Publications

Publishers
  1. Nature Publishing Group (2594)
  2. American Association for Cancer Research (2194)
  3. Elsevier Inc. (1937)
  4. American Society of Hematology (1553)
  5. Cell Press (1421)
  6. American Society of Clinical Oncology (1379)

More Publishers

Results (22468)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • How sure are you, doctor? A standardized lexicon to describe the radiologists level of certainty
    Journal Article

    Panicek, D. M.; Hricak, H.
    American Journal of Roentgenology (2016)

    Fulltext@MSK | Save
  • Information preferences and short-term psychological responses to multiplex genetic testing among individuals at risk for hereditary breast cancer
    Meeting Abstract

    Robson, M. E.; Gaissert, P.; Salo-Mullen, E. E.; Amoroso, K.; Sheehan, M.; Berliner, J. L.; Trottier, M.; Arnold, A. G.; Sekhri, N.; Marcell, V.; more...
    Cancer Research (2016)

    Fulltext@MSK | Save
  • Germline CDH1 mutations in lobular carcinoma in situ
    Meeting Abstract

    Reyes, S. A.; Sakr, R. A.; Schizas, M.; Towers, R.; Park, A. Y.; Ng, C. K. Y.; Weigelt, B.; Reis-Filho, J. S.; King, T. A.
    Cancer Research (2016)

    Fulltext@MSK | Save
  • Capturing intra-tumor genetic heterogeneity in cell-free plasma DNA from patients with oligometastatic breast cancer
    Meeting Abstract

    Ng, C. K. Y.; Bidard, F. C.; Piscuoglio, S.; Lim, R. S.; Pierga, J. Y.; Cottu, P.; Vincent-Salomon, A.; Viale, A.; Norton, L.; Sigal, B.; more...
    Cancer Research (2016)

    Fulltext@MSK | Save
  • A functional assay for homologous recombination (HR) DNA repair and whole exome sequencing reveal that HR-defective sporadic breast cancers are enriched for genetic alterations in DNA repair genes
    Meeting Abstract

    Powell, S. N.; Riaz, N.; Mutter, R. W.; Ng, C. K. Y.; Delsite, R.; Piscuoglio, S.; King, T. A.; Martelotto, L.; Sakr, R.; Brogi, E.; more...
    Cancer Research (2016)

    Fulltext@MSK | Save
  • Lobular carcinoma in situ displays intra-lesion genetic heterogeneity and its progression to invasive disease involves clonal selection and variations in mutational processes
    Meeting Abstract

    Reis, J. S.; Schizas, M.; Piscuoglio, S.; Sakr, R. A.; Ng, C. K. Y.; Lim, R. S.; Carniello, J. V. S.; Towers, R.; Martelotto, L.; Giri, D. D.; more...
    Cancer Research (2016)

    Fulltext@MSK | Save
  • Single cell sequencing analysis of formalin-fixed paraffin-embedded ductal carcinomas in situ and invasive breast cancers reveals clonal selection in the progression from in situ to invasive disease
    Meeting Abstract

    Martelotto, L. G.; Baslan, T.; Kendall, J.; Rodgers, L.; Cox, H.; King, T. A.; Weigelt, B.; Hicks, J.; Reis-Filho, J. S.
    Cancer Research (2016)

    Fulltext@MSK | Save
  • Neratinib for ERBB2 mutant, HER2 non-amplified, metastatic breast cancer: Preliminary analysis from a multicenter, open-label, multi-histology phase II basket trial
    Meeting Abstract

    Hyman, D. M.; Piha-Paul, S. A.; RodoĢn, J.; Saura, C.; Puzanov, I.; Shapiro, G. I.; Loi, S.; Joensuu, H.; Hanrahan, A. J.; Modi, S.; more...
    Cancer Research (2016)

    Fulltext@MSK | Save
  • Androgen receptor (AR) mutations in a cohort of patients with breast cancer (BC) who have undergone tumor genomic profiling
    Meeting Abstract

    Gucalp, A.; Proverbs-Singh, T. A.; Razavi, P.; Chandarlapaty, S.; Patil, S.; Ross, D. S.; Zehir, A.; Baselga, J.; Hudis, C. A.; Traina, T. A.
    Cancer Research (2016)

    Fulltext@MSK | Save
  • cfDNA analysis from BOLERO-2 plasma samples identifies a high rate of ESR1 mutations: Exploratory analysis for prognostic and predictive correlation of mutations reveals different efficacy outcomes of endocrine therapy-based regimens
    Meeting Abstract

    Chandarlapaty, S.; Sung, P.; Chen, D.; He, W.; Samoila, A.; You, D.; Bhatt, T.; Patel, P.; Voi, M.; Gnant, M.; more...
    Cancer Research (2016)

    Fulltext@MSK | Save